Dr. Rietschel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
777 Old Sawmill River Rd
Tarrytown, NY 10591Phone+1 212-920-6338
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
Massachusetts General HospitalResidency, Internal Medicine, 2000 - 2003
Ruprecht Karl University Faculty of MedicineClass of 1998
Certifications & Licensure
NY State Medical License 2006 - 2026
NJ State Medical License 2009 - 2011
Clinical Trials
- Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye Start of enrollment: 2010 Jun 01
Publications & Presentations
PubMed
- 384 citationsCemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomis...Ahmet Sezer, Saadettin Kilickap, Mahmut Gumus, Igor Bondarenko, Mustafa Ozguroglu
Lancet. 2021-02-13 - 104 citationsCemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial.Miranda Gogishvili, Tamar Melkadze, Tamta Makharadze, Davit Giorgadze, Mikhail Dvorkin
Nature Medicine. 2022-11-01 - 8 citationsDose exploration results from Phase 1 study of cemiplimab, a human monoclonal programmed death (PD)-1 antibody, in Japanese patients with advanced malignancies.Shigehisa Kitano, Toshio Shimizu, Takafumi Koyama, Takahiro Ebata, Satoru Iwasa
Cancer Chemotherapy and Pharmacology. 2021-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
